{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:52:18Z","timestamp":1792428738826,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1023\/a:1007516916077","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T05:04:10Z","timestamp":1040533450000},"page":"565-571","source":"Crossref","is-referenced-by-count":21,"title":["Propiverine-Induced Parkinsonism: A Case Report and a Pharmacokinetic\/Pharmacodynamic Study in Mice"],"prefix":"10.1007","volume":"17","author":[{"given":"Hirotami","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Takanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohide","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitada","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"223198_CR1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9343(99)80104-1","volume":"99","author":"J. Avorn","year":"1995","unstructured":"J. Avorn, R. H. Bohn, H. Mogun, J. H. Gurwitz, M. Monane, D. Everitt, and A. Walker. Neuroleptic drug exposure and treatment of Parkinsonism in the elderly: a case-control study. Am. J. Med.\n99:48\u201354 (1995).","journal-title":"Am. J. Med."},{"key":"223198_CR2","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1176\/ajp.144.11.1494","volume":"144","author":"R. L. Binder","year":"1987","unstructured":"R. L. Binder, H. Kazamatsuri, T. Nashimura, and D. E. McNiel. Tardive dyskinesia and neuroleptic-induced Parkinsonism in Japan. Am. J. Psychiat.\n144:1494\u20131496 (1987).","journal-title":"Am. J. Psychiat."},{"key":"223198_CR3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","volume":"49","author":"L. Farde","year":"1992","unstructured":"L. Farde, A. L. Nordstrom, F. A. Wiesel, S. Pauli, C. Halldin, and G. Sedvall. Positron emission tomographic analysis of cental D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch. Gen. Psychiat.\n49: 538\u2013544 (1992).","journal-title":"Arch. Gen. Psychiat."},{"key":"223198_CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mds.870100223","volume":"10","author":"M. T. Dotti","year":"1995","unstructured":"M. T. Dotti and A. Federico. Amiodarone-induced Parkinsonism: a case report and pathogenetic discussion. Mov. Disord.\n10:233\u2013234 (1995).","journal-title":"Mov. Disord."},{"key":"223198_CR5","first-page":"72","volume":"44","author":"Y. Itou","year":"1996","unstructured":"Y. Itou, Y. Satou, N. Inatomi, H. Tomoda, and N. Fujii. Aprindine-HCl induced Parkinsonism. A case report. Neurol. Med.\n44:72\u201376 (1996).","journal-title":"Neurol. Med."},{"key":"223198_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.870080127","volume":"8","author":"J. F. Marti Masso","year":"1993","unstructured":"J. F. Marti Masso, N. Carrera, and M. Urtasun. Drug-induced Parkinsonism: a growing list. Mov. Disord.\n8:125\u2013126 (1993).","journal-title":"Mov. Disord."},{"key":"223198_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.34.1.20","volume":"34","author":"F. Gjerris","year":"1971","unstructured":"F. Gjerris. Transitory procaine-induced Parkinsonism. J. Neurol. Neurosurg. Psychiat.\n34:20\u201322 (1971).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"223198_CR8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0022-3565(24)37850-4","volume":"287","author":"A. Matsui","year":"1998","unstructured":"A. Matsui, H. Matsuo, H. Takanaga, S. Sasaki, M. Maeda, and Y. Sawada. Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain. J. Pharmacol. Exp. Ther.\n287:725\u2013732 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"223198_CR9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(86)91223-7","volume":"1","author":"C. Chouza","year":"1986","unstructured":"C. Chouza, A. Scaramelli, J. L. Caamano, O. De Medina, R. Aljanati, and S. Romero. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. Lancet\n1:1303\u20131304 (1986).","journal-title":"Lancet"},{"key":"223198_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mds.870120119","volume":"12","author":"A. Negrotti","year":"1997","unstructured":"A. Negrotti and S. Calzetti. A long-term follow-up study of cinnarizine-and flunarizine-induced Parkinsonism. Mov. Disord.\n12:107\u2013110 (1997).","journal-title":"Mov. Disord."},{"key":"223198_CR11","first-page":"873","volume":"37","author":"Y. Sugiyama","year":"1997","unstructured":"Y. Sugiyama. Parkinsonism induced by propiverine hydrochloride: Report of 3 cases. Clin. Neurol.\n37:873\u2013875 (1997).","journal-title":"Clin. Neurol."},{"key":"223198_CR12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00002512-199405020-00006","volume":"5","author":"O. S. Gershanik","year":"1994","unstructured":"O. S. Gershanik. Drug-induced Parkinsonism in the aged. Drugs Aging\n5:127\u2013132 (1994).","journal-title":"Drugs Aging"},{"key":"223198_CR13","first-page":"675","volume":"25","author":"K. Haraguchi","year":"1997","unstructured":"K. Haraguchi, K. Ito, H. Kotaki, Y. Sawada, and T. Iga. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. Drug Metab. Disp.\n25:675\u2013684 (1997).","journal-title":"Drug Metab. Disp."},{"key":"223198_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(90)90291-D","volume":"182","author":"K. Ossowska","year":"1990","unstructured":"K. Ossowska, M. Karcz, J. Wardas, and S. Wolfarth. Striatal and nucleus accumbents D1\/D2 dopamine receptors in neuroleptic catalepsy. Eur. J. Pharmacol.\n182:327\u2013334 (1990).","journal-title":"Eur. J. Pharmacol."},{"key":"223198_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1099-081X(199803)19:2<115::AID-BDD86>3.0.CO;2-Q","volume":"19","author":"K. Haraguchi","year":"1998","unstructured":"K. Haraguchi, K. Ito, H. Kotaki, Y. Sawada, and T. Iga. Catalepsy induced by calcium channel blockers in mice. Biopharm. Drug Disp.\n19:115\u2013122 (1998).","journal-title":"Biopharm. Drug Disp."},{"key":"223198_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O. H. Lowry","year":"1951","unstructured":"O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurements with the Folin phenol reagent. J. Biol. Chem.\n193:265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"key":"223198_CR17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","volume":"4","author":"K. Yamaoka","year":"1981","unstructured":"K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio.-Dyn.\n4:879\u2013885 (1981).","journal-title":"J. Pharmacobio.-Dyn."},{"key":"223198_CR18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1248\/bpb1978.9.409","volume":"9","author":"K. Yokogawa","year":"1986","unstructured":"K. Yokogawa, E. Nakashima, F. Ichimura, and T. Yamana. Fundamental pharmacokinetic properties of biperiden: tissue distribution and elimination in rabbits. J. Pharmacobio.-Dyn.\n9:409\u2013416 (1986).","journal-title":"J. Pharmacobio.-Dyn."},{"key":"223198_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0773.1987.tb01722.x","volume":"60","author":"E. K. G. Syvalahti","year":"1987","unstructured":"E. K. G. Syvalahti, L. Lauren, J. Markkanen, and R. Kunelius. Interaction of psychotropic drugs with brain muscarinic cholinoceptors: similarities of biperiden with pirenzepine in receptor binding properties. Pharmacol. Toxicol.\n60:66\u201369 (1987).","journal-title":"Pharmacol. Toxicol."},{"key":"223198_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0306-4530(83)90046-X","volume":"8","author":"B. M. Davis","year":"1983","unstructured":"B. M. Davis, A. A. Mathe, R. C. Mohs, M. I. Levy, and K. L. Davis. Effects of propantheline bromide on basal growth hormone, cortisol and prolactin levels. Psychoneuroendocrinol.\n8:103\u2013107 (1983).","journal-title":"Psychoneuroendocrinol."},{"key":"223198_CR21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-3565(25)13294-1","volume":"247","author":"J. F. Kachur","year":"1988","unstructured":"J. F. Kachur, J. S. Peterson, J. P. Carter, W. Janusz Rzeszotarski, R. C. Hanson, and L. Noronha-Blob. R and S enantiomers of oxibutynin: pharmacological effects in guinea pig bladder and intestine. J. Pharmacol. Exp. Ther.\n247:867\u2013872 (1988).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"223198_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005344-197909000-00008","volume":"1","author":"K. Hashimoto","year":"1979","unstructured":"K. Hashimoto, H. Satoh, and S. Imai. Effects of etafenone and antiarrhythmic drugs on Na and Ca channels of guinea pig atrial muscle. J. Cardiovascular Pharmacol.\n1:561\u2013571 (1979).","journal-title":"J. Cardiovascular Pharmacol."},{"key":"223198_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1442-2042.1997.tb00215.x","volume":"4","author":"Y. Sasaki","year":"1997","unstructured":"Y. Sasaki, K. Hamada, C. Yamazaki, T. Seto, Y. Kimura, Y. Ukai, Y. Yoshikuni, and K. Kimura. Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency. Int. J. Urol.\n4:401\u2013406 (1997).","journal-title":"Int. J. Urol."},{"key":"223198_CR24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF00167244","volume":"348","author":"H. Tokuno","year":"1993","unstructured":"H. Tokuno, J. U. Chowdhury, and T. Tomita. Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle. Naunyn-Schmiedebergs Arch. Pharmacol.\n348:659\u2013662 (1993).","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"223198_CR25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00005344-199424050-00004","volume":"24","author":"S. P. Lubic","year":"1994","unstructured":"S. P. Lubic, K. P. Nguyen, B. Dave, and J. C. Giacomini. Antiarrhythmic agent amiodarone possesses calcium channel blocker properties. J. Cardiovascular Pharmacol.\n24:707\u2013714 (1994).","journal-title":"J. Cardiovascular Pharmacol."},{"key":"223198_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-2952(91)90675-U","volume":"42","author":"M. Yoshizumi","year":"1991","unstructured":"M. Yoshizumi, A. Nakanishi, H. Houchi, K. Morita, I. Katou, M. Oka. Characterization of palytoxin-induced catecholamine secretion from cultured bovine adrenal chromaffin cells. Effects of Na+\u00b6 and Ca2+\u00b6 channel blockers. Biochem. Pharmacol.\n42:17\u201323 (1991).","journal-title":"Biochem. Pharmacol."},{"key":"223198_CR27","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0022-5347(25)00380-5","volume":"240","author":"G. T. Bolger","year":"1986","unstructured":"G. T. Bolger, K. A. Marcus, J. W. Daly, and P. Skolnick. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes. J. Pharmacol. Exp. Ther.\n240:922\u2013930 (1986).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"223198_CR28","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0022-3565(25)12200-3","volume":"275","author":"M. Bencherif","year":"1995","unstructured":"M. Bencherif, C. M. Eisenhour, R. J. Prince, P. M. Lippiello, and R. J. Lukas. The \u201ccalcium antagonist\u201d TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes. J. Pharmacol. Exp. Ther.\n275:1418\u20131426 (1995).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"223198_CR29","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1021\/jm00109a010","volume":"34","author":"T. C. Adams","year":"1991","unstructured":"T. C. Adams, A. C. Dupont, J. Paul Carter, J. F. Kachur, M. E. Guzewska, W. Janusz Rzeszotarski, S. G. Farmer, L. Noronha-Blob, and C. Kaiser. Aminoalkynyldithianes. A new class of calcium channel blockers. J. Med. Chem.\n34:1585\u20131593 (1991).","journal-title":"J. Med. Chem."},{"key":"223198_CR30","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1073\/pnas.80.16.5122","volume":"80","author":"R. J. Gould","year":"1983","unstructured":"R. J. Gould, K. M. M. Murphy, I. J. Reynold, and S. H. Snyder. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc. Natl. Acad. Sci. USA\n80:5152\u20135125. (1983).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007516916077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007516916077\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007516916077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:37:12Z","timestamp":1754033832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007516916077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["223198"],"URL":"https:\/\/doi.org\/10.1023\/a:1007516916077","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}